Directory

>

Charles O'neill

avatar

Charles O'neill

CoFounder and Chairman of the Board of Directors | OSOD, Ocular Services On Demand

Sonoma, California, United States

View contact details (it's free)

Charles O'neill

Summary

Charles O'Neill is an accomplished Consulting Nonclinical Drug Developer and Life Science Investor with a robust background in pharmaceuticals and biotechnology. He has co-founded and led several companies, including Mcal Therapeutics and Black Sheep Ventures, focusing on innovative therapies for various medical conditions. With extensive experience at renowned organizations like BioMarin Pharmaceutical and Genentech, Charles has a proven track record in pharmacological sciences and drug development. He holds a Ph.D. in Pharmacology and Toxicology from the University of California, Davis, and a B.S. in Biology from the University of Redlands. His expertise extends to consulting for life science companies, emphasizing nonclinical development and investment strategies. Charles is passionate about advancing therapeutic solutions and has a keen interest in the intersection of science and business. He is also known for fostering collaboration among experts in the field to drive innovation.

General

Generalist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Charles O'neill

Work Experience

💼

CoFounder and Chairman of the Board of Directors at

Mcal Therapeutics

February 2019 - Present

company logo

Founder and Managing Director at

Black Sheep Ventures

June 2014 - Present

company logo

Consulting Executive Director and Board Member at

OSOD, Ocular Services On Demand

February 2014 - Present

company logo

VP Pharmacological Sciences at

Biomarin Pharmaceutical

April 2003 - May 2023

company logo

Co-Founder at

SARcode Bioscience Inc.

January 2006 - April 2013

company logo

Sr. Scientist at

Genentech

January 1995 - January 2003

company logo

Assistant Research Professor at

UC Davis Health

January 1994 - January 1995

company logo

Post-Doctoral Fellow at

The National Institutes of Health

January 1992 - January 1994

company logo

VP, Pharmacological Sciences at

BioMarin Pharmaceutical Inc.

June 2023

Logos provided by Logo.dev

Charles O'neill

Education

University of California, Davis, Ph.D.

January 1987 - January 1992

University of Redlands, B.S.

January 1981 - January 1985

Frequently Asked Questions about Charles O'neill

What is Charles O'neill email address?

Charles O'neill's primary email address is *******@ocularservices.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Charles O'neill work for?

Charles O'neill is a CoFounder and Chairman of the Board of Directors at OSOD, Ocular Services On Demand, a company specializing in Biological products, except diagnostic.

Where Charles O'neill graduated from?

Charles O'neill holds a degree in Pharmacology And Toxicology from University of California, Davis.

How can I directly contact Charles O'neill?

To contact Charles O'neill directly, you can use the email address *******@ocularservices.com. Complete contact information is available upon registration with Muraena.

Who is Charles O'neill?

Charles O'Neill is an accomplished Consulting Nonclinical Drug Developer and Life Science Investor with a robust background in pharmaceuticals and biotechnology. He has co-founded and led several companies, including Mcal Therapeutics and Black Sheep Ventures, focusing on innovative therapies for various medical conditions. With extensive experience at renowned organizations like BioMarin Pharmaceutical and Genentech, Charles has a proven track record in pharmacological sciences and drug development. He holds a Ph.D. in Pharmacology and Toxicology from the University of California, Davis, and a B.S. in Biology from the University of Redlands. His expertise extends to consulting for life science companies, emphasizing nonclinical development and investment strategies. Charles is passionate about advancing therapeutic solutions and has a keen interest in the intersection of science and business. He is also known for fostering collaboration among experts in the field to drive innovation.

Charles`s contact details

mail

*******@ocularservices.com

Colleagues

View Contact details (it's free)
Request Profile Removal